Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Michael Szarek

Concepts (294)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Acute Coronary Syndrome
35
2024
267
6.170
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
40
2025
411
5.370
Why?
Antibodies, Monoclonal, Humanized
37
2025
759
4.190
Why?
Anticholesteremic Agents
22
2024
146
4.100
Why?
Cholesterol, LDL
39
2025
361
3.200
Why?
Lipoprotein(a)
16
2025
67
3.130
Why?
Peripheral Arterial Disease
14
2024
458
2.070
Why?
Glycosides
8
2025
37
2.020
Why?
Heptanoic Acids
20
2014
62
1.740
Why?
Cardiovascular Diseases
23
2025
2018
1.730
Why?
Stroke
14
2022
1064
1.690
Why?
Myocardial Infarction
17
2024
1014
1.620
Why?
Pyrroles
20
2014
192
1.620
Why?
Dyslipidemias
8
2025
177
1.480
Why?
Ischemic Attack, Transient
4
2020
60
1.440
Why?
Diabetes Mellitus, Type 2
15
2025
2430
1.270
Why?
Proprotein Convertase 9
14
2024
68
1.150
Why?
Treatment Outcome
52
2025
10163
1.140
Why?
Eicosapentaenoic Acid
2
2025
36
1.120
Why?
Platelet Aggregation Inhibitors
10
2024
439
1.030
Why?
Angina, Unstable
7
2019
77
1.020
Why?
Brain Ischemia
7
2022
304
0.960
Why?
Rivaroxaban
12
2024
254
0.960
Why?
Double-Blind Method
29
2025
1860
0.940
Why?
Hypertriglyceridemia
1
2024
39
0.880
Why?
Antibodies, Monoclonal
5
2023
1355
0.780
Why?
Heart Failure
7
2024
2150
0.780
Why?
Renal Insufficiency, Chronic
6
2025
564
0.740
Why?
Humans
109
2025
128524
0.660
Why?
Hypercholesterolemia
7
2020
101
0.650
Why?
Aged
57
2025
21971
0.630
Why?
Drug Therapy, Combination
13
2024
1009
0.630
Why?
Carcinoma, Renal Cell
1
2021
179
0.620
Why?
Lower Extremity
8
2022
404
0.610
Why?
Middle Aged
54
2025
30893
0.610
Why?
Patient Admission
1
2019
184
0.590
Why?
Simvastatin
4
2010
55
0.560
Why?
Kidney Neoplasms
1
2021
349
0.540
Why?
Aspirin
10
2024
378
0.490
Why?
Male
66
2025
62883
0.490
Why?
Female
65
2025
68127
0.460
Why?
Risk Factors
19
2024
9727
0.460
Why?
Patient Readmission
1
2019
664
0.450
Why?
Venous Thromboembolism
3
2023
274
0.440
Why?
Global Health
3
2021
326
0.430
Why?
Ischemia
5
2022
395
0.410
Why?
Life Change Events
1
2014
148
0.410
Why?
Secondary Prevention
5
2019
220
0.400
Why?
Triglycerides
3
2024
524
0.400
Why?
Serine Proteinase Inhibitors
3
2024
43
0.390
Why?
Career Choice
1
2014
211
0.380
Why?
Factor Xa Inhibitors
6
2024
169
0.380
Why?
Markov Chains
2
2010
116
0.380
Why?
Cholesterol
3
2022
406
0.340
Why?
Risk Assessment
8
2024
3256
0.330
Why?
Time Factors
10
2024
6503
0.330
Why?
Students, Medical
1
2014
314
0.320
Why?
Atherosclerosis
2
2024
405
0.320
Why?
Infectious Disease Transmission, Vertical
1
2010
165
0.310
Why?
Apolipoproteins B
6
2022
43
0.310
Why?
Coronary Disease
5
2009
384
0.310
Why?
Vascular Surgical Procedures
2
2021
293
0.300
Why?
Biomarkers
9
2025
3881
0.290
Why?
Follow-Up Studies
8
2023
4898
0.290
Why?
Endovascular Procedures
2
2022
303
0.290
Why?
Albuminuria
3
2024
181
0.270
Why?
Models, Statistical
1
2010
625
0.260
Why?
Randomized Controlled Trials as Topic
5
2024
1358
0.260
Why?
Cholesterol, HDL
4
2019
203
0.260
Why?
Proportional Hazards Models
9
2019
1208
0.250
Why?
Survival Analysis
1
2008
1265
0.240
Why?
Anticoagulants
4
2023
613
0.230
Why?
Hemorrhage
6
2024
644
0.230
Why?
Rosuvastatin Calcium
2
2022
20
0.230
Why?
HIV-1
1
2010
840
0.230
Why?
Internship and Residency
1
2014
1054
0.220
Why?
Primary Health Care
1
2014
1638
0.210
Why?
Glomerular Filtration Rate
2
2024
681
0.210
Why?
Fibrin Fibrinogen Degradation Products
1
2023
82
0.200
Why?
Antifibrinolytic Agents
1
2023
48
0.200
Why?
Hyperlipidemias
1
2003
126
0.200
Why?
RNA, Small Interfering
1
2024
571
0.200
Why?
Hospitalization
6
2023
2071
0.190
Why?
Blood Coagulation Disorders
1
2023
162
0.190
Why?
Muscles
1
2022
323
0.180
Why?
Cataract
1
2023
194
0.170
Why?
Phenylurea Compounds
1
2021
89
0.170
Why?
Quinolines
1
2021
149
0.170
Why?
Kidney Diseases
1
2023
368
0.170
Why?
Renal Insufficiency
1
2021
148
0.160
Why?
Health Status
1
2024
751
0.160
Why?
Colonic Neoplasms
1
2021
240
0.160
Why?
Patient Care Team
1
2024
600
0.160
Why?
Thrombosis
1
2022
321
0.150
Why?
Lipids
4
2010
624
0.150
Why?
Multifactorial Inheritance
1
2019
149
0.150
Why?
Venous Thrombosis
1
2020
158
0.150
Why?
Liver X Receptors
1
2018
30
0.150
Why?
Coronary Artery Bypass
1
2019
222
0.140
Why?
Apolipoproteins E
1
2018
78
0.140
Why?
Diabetes Complications
1
2019
224
0.140
Why?
Atrial Fibrillation
1
2022
378
0.140
Why?
Cost-Benefit Analysis
1
2020
581
0.140
Why?
Dose-Response Relationship, Drug
6
2021
1943
0.140
Why?
Neoplasms, Experimental
1
2018
169
0.140
Why?
Myeloid-Derived Suppressor Cells
1
2018
63
0.140
Why?
Prospective Studies
8
2022
7043
0.140
Why?
Diabetes Mellitus, Type 1
2
2023
3618
0.130
Why?
Myocardial Ischemia
3
2007
249
0.130
Why?
HIV Infections
1
2010
2703
0.120
Why?
Phospholipids
2
2009
209
0.120
Why?
Neoplasm Recurrence, Local
1
2021
957
0.120
Why?
Hospital Mortality
1
2019
844
0.120
Why?
Hypoglycemic Agents
4
2024
1214
0.120
Why?
Killer Cells, Natural
1
2018
425
0.120
Why?
Immunotherapy, Adoptive
1
2018
295
0.120
Why?
Proprotein Convertases
1
2014
15
0.120
Why?
Receptors, Interleukin-3
1
2014
5
0.110
Why?
C-Reactive Protein
3
2022
396
0.110
Why?
Colorectal Neoplasms
1
2021
753
0.110
Why?
Disease-Free Survival
2
2018
656
0.110
Why?
Adult
14
2023
35315
0.110
Why?
Antigens, Neoplasm
2
2006
310
0.110
Why?
Coronary Artery Disease
1
2019
677
0.100
Why?
Skin Neoplasms
2
2014
832
0.100
Why?
Neoplasms
2
2023
2465
0.100
Why?
Clinical Trials as Topic
3
2008
998
0.100
Why?
Hematologic Neoplasms
1
2014
139
0.100
Why?
Clinical Decision-Making
1
2015
302
0.100
Why?
Injections, Subcutaneous
2
2024
145
0.100
Why?
Developing Countries
1
2014
283
0.100
Why?
Immunity, Innate
1
2018
803
0.100
Why?
Diabetes Mellitus
1
2020
1001
0.090
Why?
Recombinant Fusion Proteins
1
2014
632
0.090
Why?
Leukemia, Myeloid, Acute
1
2018
591
0.090
Why?
Urban Population
1
2014
438
0.090
Why?
Heparin
2
2023
240
0.090
Why?
Sodium-Glucose Transporter 1
2
2020
10
0.090
Why?
Stroke Volume
2
2024
588
0.090
Why?
Dendritic Cells
1
2014
477
0.090
Why?
Bottle Feeding
1
2010
21
0.090
Why?
Norway
1
2010
42
0.090
Why?
Denmark
1
2010
44
0.090
Why?
Netherlands
1
2010
77
0.090
Why?
Finland
1
2010
90
0.090
Why?
Serum Amyloid A Protein
2
2007
30
0.090
Why?
Sweden
1
2010
92
0.090
Why?
Antineoplastic Agents
1
2021
2058
0.090
Why?
Likelihood Functions
1
2010
136
0.090
Why?
Arteries
2
2022
266
0.080
Why?
Risk
6
2008
852
0.080
Why?
Aged, 80 and over
7
2020
7040
0.080
Why?
Myocardial Revascularization
1
2009
69
0.080
Why?
Probability
1
2010
308
0.080
Why?
Statistics, Nonparametric
1
2010
423
0.080
Why?
Hydroxymethylglutaryl CoA Reductases
1
2009
14
0.080
Why?
Biomarkers, Tumor
2
2006
1182
0.080
Why?
Practice Guidelines as Topic
3
2019
1490
0.080
Why?
Melanoma
2
2006
749
0.080
Why?
United States Government Agencies
1
2008
6
0.080
Why?
Inflammation
4
2023
2664
0.070
Why?
Biometry
1
2008
69
0.070
Why?
Postoperative Complications
1
2019
2479
0.070
Why?
Cell Line, Tumor
3
2021
3160
0.070
Why?
Tissue Plasminogen Activator
2
2022
220
0.070
Why?
United States
3
2019
13876
0.070
Why?
Counseling
1
2010
386
0.070
Why?
Incidence
3
2022
2619
0.070
Why?
Recurrence
4
2019
1001
0.070
Why?
Decision Making
1
2014
850
0.070
Why?
Breast Feeding
1
2010
421
0.070
Why?
Fibrinolytic Agents
2
2022
249
0.070
Why?
Data Interpretation, Statistical
1
2008
335
0.070
Why?
Reactive Oxygen Species
1
2009
579
0.070
Why?
Acute Disease
3
2021
968
0.060
Why?
Cancer Vaccines
1
2006
165
0.060
Why?
Lipoproteins, HDL
1
2005
85
0.060
Why?
Antigen-Antibody Complex
1
2004
84
0.060
Why?
CD40 Ligand
1
2004
38
0.060
Why?
Medication Adherence
1
2009
573
0.060
Why?
Lipoproteins, LDL
1
2004
126
0.060
Why?
Subtilisins
1
2023
10
0.050
Why?
Thromboplastin
1
2023
69
0.050
Why?
Ezetimibe
1
2022
26
0.050
Why?
Creatine Kinase
1
2022
75
0.050
Why?
Metabolic Syndrome
1
2005
340
0.050
Why?
Numbers Needed To Treat
1
2021
7
0.050
Why?
Plasma Membrane Neurotransmitter Transport Proteins
1
2021
4
0.050
Why?
Pharmacogenomic Testing
1
2022
59
0.050
Why?
Creatine
1
2021
55
0.050
Why?
Inflammation Mediators
1
2004
500
0.050
Why?
Goals
1
2022
162
0.050
Why?
Receptors, Immunologic
1
2022
209
0.040
Why?
Algorithms
1
2008
1616
0.040
Why?
Membrane Transport Proteins
1
2021
148
0.040
Why?
Diabetic Nephropathies
1
2024
277
0.040
Why?
Disease Progression
2
2024
2603
0.040
Why?
Proto-Oncogene Proteins p21(ras)
1
2021
259
0.040
Why?
Mycoses
1
2020
70
0.040
Why?
Ventricular Function, Left
1
2023
525
0.040
Why?
Odds Ratio
3
2009
1022
0.040
Why?
Mice, Nude
1
2021
682
0.040
Why?
Diarrhea
1
2020
177
0.040
Why?
Antigens, CD
1
2022
479
0.040
Why?
Hypotension
1
2020
114
0.040
Why?
Propensity Score
1
2021
261
0.040
Why?
Age Factors
1
2007
3117
0.040
Why?
Patient Education as Topic
1
2024
734
0.040
Why?
Placebo Effect
1
2019
56
0.040
Why?
Sex Characteristics
1
2024
727
0.040
Why?
Sex Factors
1
2024
1949
0.040
Why?
Transplantation, Haploidentical
1
2018
21
0.040
Why?
Diabetic Ketoacidosis
1
2020
198
0.040
Why?
American Heart Association
1
2019
309
0.040
Why?
Nerve Tissue Proteins
1
2021
567
0.040
Why?
Cell Count
1
2018
314
0.040
Why?
Mice, SCID
1
2018
345
0.030
Why?
Erythrocytes
1
2022
670
0.030
Why?
Cohort Studies
2
2022
5369
0.030
Why?
Infant
1
2010
8913
0.030
Why?
Muscular Diseases
2
2008
110
0.030
Why?
Kidney
1
2024
1305
0.030
Why?
Liver
1
2024
1827
0.030
Why?
Vascular Diseases
1
2019
236
0.030
Why?
Morbidity
1
2017
302
0.030
Why?
Mice, Inbred NOD
1
2018
582
0.030
Why?
Apolipoproteins
2
2007
38
0.030
Why?
Membrane Proteins
1
2022
1108
0.030
Why?
Immunoglobulin M
2
2009
268
0.030
Why?
Genome-Wide Association Study
1
2022
1337
0.030
Why?
Cytoplasm
2
2006
258
0.030
Why?
Tissue Donors
1
2018
386
0.030
Why?
Cause of Death
1
2017
391
0.030
Why?
Xenograft Model Antitumor Assays
1
2018
810
0.030
Why?
Fluorobenzenes
1
2014
15
0.030
Why?
Interleukin-3
1
2014
24
0.030
Why?
Syndrome
2
2007
335
0.030
Why?
Thrombolytic Therapy
1
2015
132
0.030
Why?
Diphtheria Toxin
1
2014
61
0.030
Why?
Cell Proliferation
1
2021
2335
0.030
Why?
Serine Endopeptidases
1
2014
117
0.030
Why?
Oxidation-Reduction
2
2009
1001
0.030
Why?
Multivariate Analysis
2
2007
1494
0.030
Why?
Acute Kidney Injury
1
2020
774
0.030
Why?
Mice
2
2021
16579
0.030
Why?
Prognosis
3
2005
3780
0.030
Why?
Quality of Life
1
2024
2680
0.030
Why?
Immunoglobulin G
2
2009
837
0.030
Why?
Child, Preschool
2
2005
10373
0.030
Why?
Neoplasm Staging
2
2006
1288
0.020
Why?
CD8-Positive T-Lymphocytes
1
2018
840
0.020
Why?
Interleukin-6
2
2007
716
0.020
Why?
Adolescent
3
2006
20213
0.020
Why?
Mice, Knockout
1
2018
2752
0.020
Why?
Molecular Targeted Therapy
1
2014
387
0.020
Why?
Pyrimidines
1
2014
444
0.020
Why?
Predictive Value of Tests
2
2006
1936
0.020
Why?
Sulfonamides
1
2014
500
0.020
Why?
Mutation
1
2021
3692
0.020
Why?
Pilot Projects
1
2015
1558
0.020
Why?
Autoantibodies
2
2009
1463
0.020
Why?
Ireland
1
2008
27
0.020
Why?
Thromboembolism
1
2009
102
0.020
Why?
Apolipoprotein A-I
1
2008
28
0.020
Why?
Europe
1
2009
362
0.020
Why?
Lipoproteins
1
2009
171
0.020
Why?
United Kingdom
1
2008
256
0.020
Why?
Animals
2
2021
34501
0.020
Why?
Child
2
2005
20721
0.020
Why?
Drug Prescriptions
1
2009
250
0.020
Why?
Severity of Illness Index
1
2015
2736
0.020
Why?
Cerebral Infarction
1
2006
41
0.020
Why?
Gastrointestinal Diseases
1
2008
197
0.020
Why?
ROC Curve
1
2007
501
0.020
Why?
Hematuria
1
2005
12
0.020
Why?
Immunotherapy, Active
1
2005
9
0.020
Why?
Cerebral Hemorrhage
1
2006
107
0.020
Why?
Aspartate Aminotransferases
1
2005
85
0.020
Why?
Alanine Transaminase
1
2005
150
0.010
Why?
Apolipoprotein B-100
1
2004
10
0.010
Why?
Drug Utilization
1
2005
167
0.010
Why?
Drug Administration Schedule
1
2007
757
0.010
Why?
Arteriosclerosis
1
2004
88
0.010
Why?
Chemical and Drug Induced Liver Injury
1
2005
134
0.010
Why?
Angina Pectoris
1
2004
67
0.010
Why?
Enzyme-Linked Immunosorbent Assay
1
2006
814
0.010
Why?
Solubility
1
2004
229
0.010
Why?
Troponin
1
2003
50
0.010
Why?
Research Design
1
2009
1038
0.010
Why?
Databases, Factual
1
2008
1268
0.010
Why?
Heart Arrest
1
2004
327
0.010
Why?
Pain
1
2005
756
0.010
Why?
Retrospective Studies
2
2007
14460
0.010
Why?
Brain
1
2007
2618
0.010
Why?
Szarek's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)